Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 2;16(1):55.
doi: 10.1186/s12974-019-1444-1.

Murine astrocytes produce IL-24 and are susceptible to the immunosuppressive effects of this cytokine

Affiliations

Murine astrocytes produce IL-24 and are susceptible to the immunosuppressive effects of this cytokine

Amanda R Burmeister et al. J Neuroinflammation. .

Abstract

Background: Glia are key regulators of inflammatory responses within the central nervous system (CNS) following infection or trauma. We have previously demonstrated the ability of activated glia to rapidly produce pro-inflammatory mediators followed by a transition to an anti-inflammatory cytokine production profile that includes the immunosuppressive cytokine interleukin (IL)-10 and the closely related cytokine IL-19. IL-24, another member of the IL-10 family, has been studied in a number of inflammatory conditions in the periphery and is known to modulate immune cell activity. However, the ability of glia to produce IL-24 remains unclear and the effects of this pleiotropic cytokine on glial immune functions have not been investigated.

Methods: In this study, we have assessed whether primary murine glia produce IL-24 following stimulation and evaluated the effect of this cytokine on the immune responses of such cells. We have utilized RT-PCR and immunoblot analyses to assess the expression of IL-24 and its cognate receptors by astrocytes following challenge with bacteria or their components. Furthermore, we have determined the effect of recombinant IL-24 on astrocyte immune signaling and responses to clinically relevant bacteria using RT-PCR and specific capture ELISAs.

Results: We demonstrate that astrocytes express IL-24 mRNA and release detectable amounts of this cytokine protein in a delayed manner following bacterial challenge. In addition, we have determined that glia constitutively express the cognate receptors for IL-24 and show that such expression can be increased in astrocytes following activation. Importantly, our results indicate that IL-24 exerts an immunosuppressive effect on astrocytes by elevating suppressor of cytokine signaling 3 expression and limiting IL-6 production following challenge. Furthermore, we have demonstrated that IL-24 can also augment the release of IL-10 by bacterially challenged astrocytes and can induce the expression of the potentially neuroprotective mediators, glutamate transporter 1, and cyclooxygenase 2.

Conclusions: The expression of IL-24 and its cognate receptors by astrocytes following bacterial challenge, and the ability of this cytokine to limit inflammatory responses while promoting the expression of immunosuppressive and/or neuroprotective mediators, raises the intriguing possibility that IL-24 functions to regulate or resolve CNS inflammation following bacterial infection in order to limit neuronal damage.

Keywords: Astrocytes; Bacterial infection; Interleukin-10; Interleukin-24; Neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All protocols involving animals were approved by the Institutional Animal Care and Use Committee of the University of North Carolina at Charlotte.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
IL-24 mRNA expression is induced in the CNS of mice following in vivo bacterial infection. Wild type C57BL/6J mice were uninfected (control, animal numbers 1 and 2) or infected by direct intracranial administration with Streptococcus pneumoniae (1 × 107 bacteria, animal numbers 3–6). At 72 h following infection, whole brain tissue was collected and expression of mRNA encoding for IL-24 was determined by semi-quantitative RT-PCR, and C57BL/6J mouse whole thymus tissue was used as a positive control (+). Relative IL-24 mRNA expression was determined by densitometric analysis and normalized to the level of the housekeeping gene GAPDH, and all data points and the mean are shown
Fig. 2
Fig. 2
Primary murine astrocytes express IL-24 following exposure to bacterial ligands for certain toll-like receptors. a Murine astrocytes were either unstimulated or challenged with LPS (5 ng/ml) for 6, 12, or 24 h, and IL-24 mRNA expression was determined by semi-quantitative (top) and real-time quantitative (bottom) RT-PCR. Expression of GAPDH mRNA housekeeping gene product is included and the image shown is representative of at least three independent experiments. Below, real-time RT-PCR data is shown as mean fold increases in product ± the SEM of three independent experiments and an asterisk indicates a statistically significant difference from unchallenged cells (p < 0.05). b Astrocytes were either unchallenged or challenged with TLR ligands; flagellin (50 and 100 ng/mL; FLG), the lipoprotein Pam3Cys (5 and 25 ng/mL; PAM), or dsRNA polyinosinic:polycytidylic acid (0.5 or 1 μg/mL; PIC) for 6 h, and IL-24 mRNA expression was determined by semi-quantitative RT-PCR. Expression of the housekeeping gene GAPDH is shown, and relative IL-24 mRNA expression was determined by densitometric analysis and normalized to unchallenged cells. Murine whole thymus tissue was used as a positive control for IL-24 expression (+). Asterisks denote statistical significance compared to unchallenged cells (p < 0.05)
Fig. 3
Fig. 3
Primary murine glia express IL-24 following bacterial challenge. a Astrocytes were uninfected or infected with Neisseria meningitidis (Nm) at MOI of 1 or 10 bacteria to glia for 6 h prior to RNA collection. IL-24 and GAPDH mRNA expression was determined by semi-quantitative RT-PCR, and the average of three separate experiments is shown as mean relative gene expression as determined by densitometric analysis normalized to the expression of the housekeeping gene GAPDH ± SEM. b Isolated primary murine microglia were uninfected or infected with N. meningitidis, Staphylococcus aureus (Sa), or S. pneumoniae (Sp) (MOI of 10:1 bacteria to microglia) for 8 h prior to RNA isolation. C57BL/6J thymus tissue was used as a positive control. Relative IL-24 gene expression was determined by densitometric analysis normalized to GAPDH gene expression and is depicted as the mean of three individual experiments ± SEM. c Astrocytes were uninfected or infected with N. meningitidis for 24 or 48 h prior to immunoblot analysis of cell medium IL-24 protein content. Expression of an irrelevant protein is shown as a loading control (lc), and the relative IL-24 expression was determined by densitometric analysis and normalized to untreated cells. Data is expressed as the mean ± the SEM of three independent experiments. Asterisk indicates a statistical significance compared to unchallenged cells (p < 0.05)
Fig. 4
Fig. 4
Primary murine glia constitutively express the IL-22Rα subunit of the Type II receptor for IL-24. a Murine astrocytes were unstimulated or challenged with LPS (1 or 5 ng/ml) for 6 or 24 h, and levels of mRNA encoding IL-22Rα and GAPDH were determined by semi-quantitative RT-PCR. b Astrocytes were uninfected or infected with N. meningitidis (Nm), S. aureus (Sa), or S. pneumoniae (Sp) at MOI of 1, 10, or 50 bacteria to glia for 24 h prior to immunoblot analysis for IL-22Rα expression. Expression of β-actin is shown as a loading control, and relative IL-22Rα expression was determined by densitometric analysis and normalized to untreated cells. Data is expressed as the mean ± the SEM of 3 independent experiments, and an asterisk indicates a statistically significant difference from unchallenged cells (p < 0.05). c Murine microglia were uninfected or infected with N. meningitidis (Nm), S. aureus (Sa), or S. pneumoniae (Sp) at MOI of 1, 10, or 50 bacteria to glia for 24 h prior to immunoblot analysis for IL-22Rα expression. Expression of β-actin is shown as a loading control and relative IL-22Rα expression was determined by densitometric analysis and normalized to untreated cells. Data is expressed as the mean ± the SEM of three independent experiments
Fig. 5
Fig. 5
IL-24 augments the expression of suppressive cytokine signaling components by murine astrocytes and limits inflammatory cytokine release by these cells. a Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 30 min and the presence of phosphorylated STAT3 and STAT1 was determined by immunoblot analysis. Expression of β-actin is shown as a loading control and these immunoblots are representative of two separate experiments. b Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 2 or 4 h, and SOCS3 mRNA expression was determined by semi-quantitative RT-PCR. Expression of the housekeeping gene product GAPDH is shown, and relative SOCS3 expression was determined by densitometric analysis and normalized to untreated cells. Data is expressed as the mean ± the SEM of three independent experiments, and an asterisk indicates a statistically significant difference from unchallenged cells at each time point (p < 0.05). c Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 8 h prior to immunoblot analysis for SOCS3 protein expression. Expression of the housekeeping gene β-actin is shown and relative SOCS3 protein expression was determined by densitometric analysis normalized to untreated cells. Asterisks indicate statistically significant differences from unchallenged cells (p < 0.05). d Astrocytes were untreated or treated with IL-24 (0.5, 3, 10, 30, or 100 ng/mL) for 4 h prior to challenge with bacterial LPS (5 ng/mL) or vehicle control for 12 h, and IL-6 secretion was determined by specific capture ELISA. Asterisks indicate a statistically significant difference (p < 0.05) from similarly challenged cells in the absence of IL-24 (n = 3). e Primary astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 4 h prior to being uninfected or infected with Nm for 48 h before cell viability analysis via MTS assay. Data is presented as the mean absorbance ± SEM for three experiments. 0.1% Triton X-100 was used as a positive control, and an asterisk indicates a statistically significant difference from unchallenged cells in the absence of IL-24 (p < 0.05)
Fig. 6
Fig. 6
IL-24 increases the expression of anti-inflammatory cytokines and neuroprotective factors by primary murine astrocytes. a Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/ml) for 4 h prior to N. meningitidis infection (Nm; MOI of 10:1 bacteria to each astrocyte) or vehicle control. At 24 or 48 h postinfection, IL-10 protein release was assessed by specific capture ELISA. Asterisks and dagger indicate a statistically significant difference from uninfected cells and similarly challenged cells in the absence of IL-24, respectively (n = 3; p < 0.05). b Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 2 or 4 h, and mRNA expression of GLT-1 was determined by semi-quantitative RT-PCR. Expression of the housekeeping gene product GAPDH is shown, and relative GLT-1 expression was determined by densitometric analysis and normalized to untreated cells. Data is expressed as the mean ± the SEM of three independent experiments, and an asterisk indicates a statistically significant difference (p < 0.05) from unchallenged cells at each time point. c Astrocytes were untreated or treated with recombinant IL-24 (10, 30, or 100 ng/mL) for 2 h and mRNA expression of COX2 was determined by semi-quantitative RT-PCR. Data is expressed as the mean ± the SEM of three independent experiments, and an asterisk indicates a statistically significant difference (p < 0.05) from unchallenged cells

References

    1. Chauhan VS, Sterka DG, Gray DL, Bost KL, Marriott I. Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol. 2008;180(12):8241–8249. doi: 10.4049/jimmunol.180.12.8241. - DOI - PMC - PubMed
    1. Barichello T, Fagundes GD, Generoso JS, Paula Moreira A, Costa CS, Zanatta JR, et al. Brain–blood barrier breakdown and pro-inflammatory mediators in neonate rats submitted meningitis by Streptococcus pneumoniae. Brain Res. 2012;1471:162–168. doi: 10.1016/j.brainres.2012.06.054. - DOI - PubMed
    1. Vellozo NS, Pereira-Marques ST, Cabral-Piccin MP, Filardy AA, Ribeiro-Gomes FL, Rigoni TS, et al. All-trans retinoic acid promotes an M1- to M2-phenotype shift and inhibits macrophage-mediated immunity to Leishmania major. Front Immunol. 2017;8(November):1560. doi: 10.3389/fimmu.2017.01560. - DOI - PMC - PubMed
    1. Xuan W, Qu Q, Zheng B, Xiong S, Fan G-H. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 2015;97(1):61–69. doi: 10.1189/jlb.1A0314-170R. - DOI - PubMed
    1. Reales-Calderón JA, Aguilera-Montilla N, Corbí ÁL, Molero G, Gil C. Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans. Proteomics. 2014;14(12):1503–1518. doi: 10.1002/pmic.201300508. - DOI - PubMed

LinkOut - more resources